Indivior Pharmaceuticals, Inc. INDV Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's net change in cash?
- Indivior Pharmaceuticals, Inc. (INDV) reported net change in cash of -$20M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's net change in cash changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's net change in cash decreased by 137.7% year-over-year, from $53M to -$20M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's net change in cash?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's net change in cash has grown at a -27.6% compound annual growth rate (CAGR), from -$327M to -$124M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.